NCT05277532

Brief Summary

Cardiometabolic risk in patients with abdominal obesity and type 1 diabetes can be moderated by life style modifications. There is an intimate link between gene regulation and circadian rhythm in mediating response to exercise in a variety of insulin sensitive organs. The aim of this project is to evaluate, by intervention, the interplay of circadian rhythm and high intensity interval training (HIIT) on glucose control and skeletal muscle metabolism in patients with overweight with or without type 1 diabetes (T1D).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
May 2022Oct 2026

First Submitted

Initial submission to the registry

February 18, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

March 14, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

May 18, 2022

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2026

Expected
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

3.5 years

First QC Date

February 18, 2022

Last Update Submit

October 10, 2024

Conditions

Keywords

high intensity interval trainingmetabolomics

Outcome Measures

Primary Outcomes (1)

  • Time in Glucose target range (4-10 mmol/L) for tissue glucose from CGM.

    Time in target glucose range (expressed as % of total time) measured by continuous subcutaneous glucose sensors following morning or afternoon HIIT respectively. Measurements are uploaded from the CGM device and analyzed.

    48 hours

Secondary Outcomes (2)

  • Tissue specific effects of HIIT in type 1 diabetes vs healthy subjects

    2 hours; muscle and blood samples are collected directly before and after HIIT, respectively.

  • Time below Glucose target range (< 4 mmol/L) for tissue glucose from CGM.

    48 hours

Study Arms (2)

Type 1 diabetes with overweight

ACTIVE COMPARATOR

High intensity interval training (HIIT), a single bout, randomly performed either in the morning or in the afternoon in a cross-over design.

Behavioral: High intensity interval training (HIIT)

Overweight but otherwise healthy control subjects

ACTIVE COMPARATOR

High intensity interval training (HIIT), a single bout, randomly performed either in the morning or in the afternoon in a cross-over design.

Behavioral: High intensity interval training (HIIT)

Interventions

HIIT performed either in the morning or in the afternoon

Overweight but otherwise healthy control subjectsType 1 diabetes with overweight

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI 25-30
  • type 1 diabetes or healthy subjects

You may not qualify if:

  • nicotine usage,
  • cardiovascular disease (CVD),
  • blood pressure \>160/95,
  • pregnancy,
  • treatment with other pharmaceutical drugs than insulin, stable dose of thyroid hormone, statins, and antihypertensive drugs (excluding beta blockers).
  • diabetes duration less than 6 months,
  • proliferative or severe non-proliferative retinopathy,
  • chronic kidney disease with glomerular filtration rate (GFR) \<60 ml/min,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ersta sjukhus

Stockholm, 11691, Sweden

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Overweight

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Ingrid Dahlman, Professor

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Eva Toft, Assoc Prof

CONTACT

Veronica Qvisth, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: A randomized crossover design (comparing morning vs afternoon exercise) in parallel groups (Type 1 diabetes and control subjects)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 18, 2022

First Posted

March 14, 2022

Study Start

May 18, 2022

Primary Completion

October 31, 2025

Study Completion (Estimated)

October 31, 2026

Last Updated

October 15, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations